Bringing new therapies to market requires more than clinical success. In this conversation, Ian Colley, chief marketing officer at DeepIntent, discusses why pharmaceutical marketing is uniquely suited to data-driven advertising and why precision is essential when reaching highly specific patient and healthcare provider audiences.
Colley examines the commercialization challenges facing the industry, including the pressure to successfully launch treatments after significant development investment. He explains how artificial intelligence is helping organizations analyze complex variables, improve audience targeting and make more informed decisions throughout the commercialization process. The discussion highlights DeepIntent's new agentic marketing platform, Cora, and how it is designed to support planning and strategy across channels rather than focusing only on campaign execution.
The interview also explores the importance of transparency and explainability in healthcare marketing. Colley discusses why visibility into data sources, reasoning and decision-making processes is critical in a highly regulated environment where privacy, compliance and trust remain top priorities.